Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes
- Elaine H. Morrato, DRPH, MPH1,
- John W. Newcomer, MD2,
- Siddhesh Kamat, MS3,
- Onur Baser, PHD4,
- James Harnett, PHARMD, MS5 and
- Brian Cuffel, PHD5
- 1Departments of Pediatrics, Health Services Management and Policy, and Clinical Pharmacy, University of Colorado Denver, Aurora, Colorado;
- 2Departments of Psychiatry, Psychology, and Medicine and the Center for Clinical Studies, Washington University School of Medicine, St. Louis, Missouri;
- 3HealthCore, Wilmington, Delaware;
- 4STATInMED, University of Michigan, Ann Arbor, Michigan;
- 5Pfizer, New York, New York.
- Corresponding author: Elaine Morrato, .